Hendrik Lambert holds a Master in Electronic Engineering and a Master in Biomedical Engineering from the University of Ghent, and obtained a PhD in Biomedical Engineering (Cum Lauda) from the same university. Meantime he has 20 years of international experience in the development of Medical Device technologies in small and large industries. All technologies were early stage, innovative and high risk technologies for treatment of cardiac, vascular and neurological diseases. Several of those technologies evolved into mature therapies that are used today worldwide as a standard of care. Clinical research associated with these developments led to several milestone publications on which he co-authors. In his function as Regulatory Affairs Manager, he was leading interactions with regulatory agencies worldwide, including FDA.
Currently he is Vice President of Clinical and Regulatory Affairs at G-Therapeutics, a startup company specialized in the development of neuromodulation devices of which he is a co-founder. The company is based in Eindhoven (NL) and in Lausanne (CH).
He is part-time Teaching Professor at the University of Ghent related to Safety and Regulations.